|
Long-Term Debt (Details)
|
3 Months Ended | 9 Months Ended | 3 Months Ended | 6 Months Ended | 9 Months Ended | 3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended | 1 Months Ended | 3 Months Ended | 9 Months Ended | 0 Months Ended | 3 Months Ended | 9 Months Ended | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Sep. 30, 2013
USD ($)
|
Sep. 30, 2012
USD ($)
|
Sep. 30, 2013
USD ($)
|
Sep. 30, 2012
USD ($)
|
Sep. 30, 2013
Novartis Note [Member]
USD ($)
|
Sep. 30, 2012
Novartis Note [Member]
USD ($)
|
Jun. 30, 2013
Novartis Note [Member]
|
Sep. 30, 2013
Novartis Note [Member]
USD ($)
|
Sep. 30, 2012
Novartis Note [Member]
USD ($)
|
Dec. 31, 2012
Novartis Note [Member]
USD ($)
|
Sep. 30, 2013
Servier Loan [Member]
USD ($)
|
Sep. 30, 2012
Servier Loan [Member]
USD ($)
|
Jul. 15, 2013
Servier Loan [Member]
|
Jan. 15, 2013
Servier Loan [Member]
|
Jul. 15, 2012
Servier Loan [Member]
|
Jan. 15, 2012
Servier Loan [Member]
|
Sep. 30, 2013
Servier Loan [Member]
USD ($)
|
Sep. 30, 2012
Servier Loan [Member]
USD ($)
|
Dec. 31, 2012
Servier Loan [Member]
USD ($)
|
Dec. 31, 2011
Servier Loan [Member]
USD ($)
|
Sep. 30, 2013
Servier Loan [Member]
EUR (€)
|
Sep. 30, 2012
General Electric Capital Corporation Term Loan [Member]
USD ($)
Installment
|
Sep. 30, 2013
General Electric Capital Corporation Term Loan [Member]
USD ($)
|
Sep. 30, 2012
General Electric Capital Corporation Term Loan [Member]
USD ($)
|
Sep. 30, 2013
General Electric Capital Corporation Term Loan [Member]
USD ($)
Installment
|
Sep. 30, 2012
General Electric Capital Corporation Term Loan [Member]
USD ($)
|
Dec. 31, 2012
General Electric Capital Corporation Term Loan [Member]
USD ($)
|
Sep. 27, 2012
General Electric Capital Corporation Term Loan [Member]
USD ($)
|
Dec. 31, 2011
General Electric Capital Corporation Term Loan [Member]
USD ($)
|
Aug. 23, 2013
Other Financings [Member]
USD ($)
|
Sep. 30, 2013
Other Financings [Member]
USD ($)
|
Sep. 30, 2012
Other Financings [Member]
USD ($)
|
Sep. 30, 2013
Other Financings [Member]
USD ($)
|
Sep. 30, 2012
Other Financings [Member]
USD ($)
|
|
| Debt Instrument [Line Items] | ||||||||||||||||||||||||||||||||||
| Maturity date | Jun. 30, 2015 | Jun. 15, 2015 | ||||||||||||||||||||||||||||||||
| Research and development expenses funded through loan facility, maximum (in hundredths) | 75.00% | |||||||||||||||||||||||||||||||||
| Maximum borrowing capacity under loan agreement | $ 50,000,000 | $ 50,000,000 | € 15,000,000 | |||||||||||||||||||||||||||||||
| Variable rate basis | six-month LIBOR | Euro Inter-Bank Offered Rate ("EURIBOR") | ||||||||||||||||||||||||||||||||
| Basis spread on variable rate (in hundredths) | 2.00% | |||||||||||||||||||||||||||||||||
| Interest rate at period end (in hundredths) | 2.41% | 2.41% | ||||||||||||||||||||||||||||||||
| Outstanding principal balance | 14,600,000 | 14,600,000 | 14,200,000 | 20,300,000 | 20,300,000 | 19,800,000 | 10,400,000 | 10,400,000 | 12,500,000 | 3,100,000 | 10,000,000 | |||||||||||||||||||||||
| Periodic Payment, Principal | 347,222 | |||||||||||||||||||||||||||||||||
| Proceeds from loan | 19,500,000 | 4,600,000 | ||||||||||||||||||||||||||||||||
| Increase (Decrease) in term loan obligation | 12,500,000 | |||||||||||||||||||||||||||||||||
| Initial interest rate during period (in hundredths) | 3.22% | |||||||||||||||||||||||||||||||||
| Interest rate during period (in hundredths) | 2.33% | 2.80% | 3.54% | 3.83% | ||||||||||||||||||||||||||||||
| Unamortized discount on debt | 8,900,000 | 8,900,000 | ||||||||||||||||||||||||||||||||
| Unrealized foreign exchange gain (loss) | 55,000 | 88,000 | (800,000) | (400,000) | (500,000) | 100,000 | ||||||||||||||||||||||||||||
| Unrealized foreign exchange gains related to re-measurement of loan discount | 200,000 | 100,000 | 100,000 | (100,000) | ||||||||||||||||||||||||||||||
| Euro to US Dollar exchange rates | 1.3520 | 1.3520 | 1.3215 | |||||||||||||||||||||||||||||||
| Amortization period for loan discount | 5 years | |||||||||||||||||||||||||||||||||
| Amortization of debt discount | 0 | (55,000) | 400,000 | 400,000 | 1,200,000 | 1,100,000 | ||||||||||||||||||||||||||||
| Carrying value of the loan | 15,800,000 | 15,800,000 | 14,200,000 | |||||||||||||||||||||||||||||||
| Recognition of deferred revenue | 400,000 | 400,000 | 1,200,000 | 1,100,000 | ||||||||||||||||||||||||||||||
| Debt issuance costs | 200,000 | 1,300,000 | ||||||||||||||||||||||||||||||||
| Final payment fee | 500,000 | 500,000 | 875,000 | |||||||||||||||||||||||||||||||
| Fixed interest rate accrued (in hundredths) | 11.71% | 11.71% | 10.90% | |||||||||||||||||||||||||||||||
| Number of monthly installments | 27 | 42 | ||||||||||||||||||||||||||||||||
| Prepayment premium year one (in hundredths) | 3.00% | 3.00% | ||||||||||||||||||||||||||||||||
| Prepayment premium year two (in hundredths) | 2.00% | 2.00% | ||||||||||||||||||||||||||||||||
| Prepayment premium year thereafter (in hundredths) | 1.00% | 1.00% | ||||||||||||||||||||||||||||||||
| Aggregate number of unregistered shares of common stock called by warrants (in shares) | 263,158 | 263,158 | 39,346 | |||||||||||||||||||||||||||||||
| Warrants exercise price (in dollars per share) | $ 1.14 | $ 1.14 | $ 3.54 | |||||||||||||||||||||||||||||||
| Immediate Term for warrants exercisable (in years) | 5 years | 5 years | ||||||||||||||||||||||||||||||||
| Fair value of warrant liability | 52,000 | 52,000 | 200,000 | 200,000 | 100,000 | |||||||||||||||||||||||||||||
| Interest expense and amortization of debt issuance costs [Abstract] | ||||||||||||||||||||||||||||||||||
| Interest expense | 1,159,000 | 1,144,000 | 3,495,000 | 3,211,000 | 90,000 | 99,000 | 272,000 | 298,000 | 508,000 | 475,000 | 1,584,000 | 1,298,000 | 547,000 | 558,000 | 1,600,000 | 1,583,000 | 14,000 | 12,000 | 39,000 | 32,000 | ||||||||||||||
| Underwritten Offering [Abstract] | ||||||||||||||||||||||||||||||||||
| Number of underwritten public offering shares (in shares) | 8,736,187 | |||||||||||||||||||||||||||||||||
| Number of common stock issued at public offering (in shares) | 1,139,502 | |||||||||||||||||||||||||||||||||
| Public offering share price (in dollars per share) | $ 3.62 | |||||||||||||||||||||||||||||||||
| Proceeds from issuance of common stock before deducting expenses | 31,600,000 | |||||||||||||||||||||||||||||||||
| Discount, commissions and estimated offering expenses | $ 2,200,000 | |||||||||||||||||||||||||||||||||